Mechanistic dissection of novel regulators of TDP-43 aggregation identified in a genome-wide CRISPR-Cas9 knockout screen
全基因组 CRISPR-Cas9 敲除筛选中发现的 TDP-43 聚集新型调节因子的机制剖析
基本信息
- 批准号:10404620
- 负责人:
- 金额:$ 3.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2023-05-30
- 项目状态:已结题
- 来源:
- 关键词:ALS patientsAddressAffectAlzheimer&aposs DiseaseAmyotrophic Lateral SclerosisAstrocytesBindingBiologyCRISPR/Cas technologyCell LineCellsCellular MorphologyClientCoculture TechniquesCollaborationsCoupledCyclic AMP-Dependent Protein KinasesDataDevelopmentDiffuseDiseaseDisease ProgressionDissectionDouble-Stranded RNAEnzyme-Linked Immunosorbent AssayFluorescence-Activated Cell SortingGenerationsGenesGenetic Predisposition to DiseaseGlobal ChangeGoalsHomeostasisImmuneImmune responseImmune signalingImportinsIn VitroIncidenceInterferon-alphaKnock-outLinkMass Spectrum AnalysisMeasuresMediatingMessenger RNAMethyltransferaseMicrogliaMindModelingModificationMolecular ChaperonesMotor NeuronsMutationNeurodegenerative DisordersNuclearNuclear ExportPathogenesisPathologicPathologyPathway interactionsPhasePhysiologic pulsePrevalenceProteinsQuality ControlRNARNA BindingRNA methylationRNA-Binding ProteinsRegulationReporterRibosomal RNARoleSignal PathwaySignal TransductionSmall RNAStainsStructureTestingTherapeuticTimeToxic effectTranslationsWestern BlottingWorkYeast Model SystemYeastsbasecrosslinking and immunoprecipitation sequencingdisease-causing mutationfollow-upfrontotemporal degenerationgenome-widein vitro testinginterestnovelpreventprotein TDP-43protein kinase Rshape analysistherapeutically effective
项目摘要
Project Summary
The mislocalization and aggregation of RNA-binding proteins (RBP) is a pathological hallmark of Amyotrophic
Lateral Sclerosis (ALS). The RBP TAR DNA-binding protein 43 (TDP-43) is of particular interest, as pathological
aggregation of TDP-43 is observed in nearly 97% of ALS patients, despite the fact that disease-causing
mutations in TDP-43 explain fewer than 5% of disease incidence. This observation suggests that misregulation
or mutation of other genes converge on TDP-43 pathology, however it remains poorly understood how the
aggregates arise or whether they can be reversed or prevented. To this end, we have developed Pulse-Shape
Analysis-based aggregation reporters for the TDP-43 that, when coupled to fluorescence activated cell sorting,
quantifies aggregation at the single cell level. This reporter was leveraged against a genome-wide CRISPR-
Cas9 knockout screen to identify regulators of TDP-43 aggregation. Reassuringly, this screen revealed known
interactors and pathways involved in TDP-43 regulation and pathology. Additionally, this work revealed several
novel proteins not previously implicated in TDP-43 biology or aggregation. Initial follow up on one top hit, SRRD,
revealed that this protein reduces TDP-43 aggregation in a mammalian aggregation model, and reduces TDP-
43-associated toxicity in a yeast model, indicating that these genes indeed modify TDP-43 aggregation.
The goal of this proposal is to mechanistically dissect how these novel regulators modify TDP-43
aggregation. Using an induced motor neuron model of TDP-43 aggregation, yeast toxicity models, and in vitro
studies, I will assess the interactors, signaling pathways, and mode of TDP-43 modification for the following four
genes: METTL5, EIF2AK2, XPO4, and SRRD. This work will not only reveal the function of uncharacterized
proteins, but dissect their heretofore unknown mechanisms in regulating TDP-43 aggregation. Through better
understanding of how TDP-43 aggregation is regulated, the field can begin to answer questions regarding the
role of TDP-43 aggregation in disease pathogenesis and progression.
By understanding the regulatory network of underlying TDP-43 aggregation, we can begin to
therapeutically modulate the pathways that contribute to disease.
项目摘要
RNA结合蛋白(RBP)的错误定位和聚集是肌营养不良的一个病理标志
侧索硬化(ALS)。RBP TAR DNA结合蛋白43(TDP-43)是一种特殊的病理性蛋白
在近97%的ALS患者中观察到TDP-43的聚集,尽管事实上
TDP-43的突变解释了不到5%的疾病发病率。这一观察表明,监管不善
或其他基因突变汇聚在TDP-43的病理上,然而仍然鲜为人知
聚集出现了,或者它们是否可以逆转或防止。为此,我们开发了脉冲形
TDP-43的基于分析的聚集报告,当与荧光激活的细胞分选相结合时,
在单个单元级别量化聚合。这位记者被用来对抗全基因组的CRISPR-
Cas9基因敲除筛选以识别TDP-43聚集的调节因子。令人放心的是,这个屏幕显示了已知的
参与TDP-43调控和病理的相互作用因子和通路。此外,这项工作揭示了几个
以前未涉及TDP-43生物或聚集的新蛋白质。对一首热门歌曲SRRD的初步跟进,
在哺乳动物聚集模型中,该蛋白降低TDP-43的聚集,并降低TDP-43的聚集。
酵母模型中的43相关毒性,表明这些基因确实改变了TDP-43的聚集。
该提案的目标是机械地剖析这些新型调节剂是如何修改TDP-43的
聚合。使用TDP-43聚集的诱导运动神经元模型、酵母菌毒性模型和体外
研究中,我将评估以下四个方面的相互作用、信号通路和TDP-43修饰模式
基因:METTL5、EIF2AK2、XPO4和SRRD。这部作品不仅将揭示未刻画的功能
蛋白质,但剖析了它们迄今未知的调节TDP-43聚集的机制。通过更好的
了解TDP-43聚集是如何调节的,该领域可以开始回答关于
TDP-43聚集在疾病发生发展中的作用。
通过了解潜在的TDP-43聚合的调控网络,我们可以开始
从治疗上调节导致疾病的途径。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Katelyn Sweeney其他文献
Katelyn Sweeney的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Katelyn Sweeney', 18)}}的其他基金
Mechanistic dissection of novel regulators of TDP-43 aggregation identified in a genome-wide CRISPR-Cas9 knockout screen
全基因组 CRISPR-Cas9 敲除筛选中发现的 TDP-43 聚集新型调节因子的机制剖析
- 批准号:
10268168 - 财政年份:2020
- 资助金额:
$ 3.42万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 3.42万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 3.42万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 3.42万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 3.42万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 3.42万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 3.42万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 3.42万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 3.42万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 3.42万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 3.42万 - 项目类别:
Research Grant